Granalix is planning a clinical trial for MS patients in which GranaGard will be administered in addition to conventional...
Preliminary experiments have shown that GranaGard can modulate the activity of mitochondrial enzymes, resulting in reduction of reactive species...
Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system and is associated with demyelination, neurodegeneration,...
Neurodegenerative diseases generate the accumulation of specific misfolded proteins, such as PrPSc prions or A-beta in Alzheimer’s diseases, and...
